Recent Finacing
Recent Raise
Novimmune is a Geneva-based biopharmaceutical company that discovers and develops monoclonal and bispecific antibody therapeutics (kappa/lambda bodies) targeting inflammatory, immune-related, orphan diseases and cancer.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors